All Type of News


Domestic pharmaceutical firms to speed up global expansion

A number of local pharmaceutical companies have established their off-shore affiliates as part of intensive efforts to increase their global presence and overcome the protracted business slump in the domestic pharmace...

Government to prop up biopharmaceutical development projects

The Ministry of Health and Welfare unveiled its plan to financially support the development of Korea's more sophisticated technologies in various fields such as Korea's biotechnology, pharmaceutical raw materials and ...

AstraZeneca Korea names new managing director

AstraZeneca Korea said that it has elected Lee Young-joon as its new managing director in charge of cardiovascular and circulatory fields. He will sit on the post from March 2. Lee has had various executive posts a...

MOHW to plan 14.5 BW subsidy for bio industry.

The domestic bio industry has grown enough to a level for any products ready to be commercialized. Now, the government announced that the bio industry would leap up to the 7th over the world until 2010 by the absolute...

2004 pharmaceutical export targeted at U$950,500 thousands.

President Chung Seung-whan of the Korea Pharmaceutical Trade Association announced in the 48th general congress at Textile House Hall at 10 a.m. on Feb. 25 that the 2004 pharmac...

CJ to introduce intradermal BCGvaccine SSI in Korea

CJ Corporation, a local maker of Capacin inj. (capreomycin) for treatment of tuberculosis infections, saidit has recently entered into an agreement with Denmark-based StatensSerumInstitute (SSI) for the exclusive dist...

SMEDDS based Hepaphil boasts of better bioavailability

KMS Company said that it has marketed Hepaphil soft capsule (biphenyl dimethyl dicarboxylate; BDD) to improve the dissolution rate of poorly water soluble drug using self-microe...

US FDA approves Alimtaas first-line regimen for mesothelioma

Eli Lilly and Company said recently that the US Food and Drug Administration approved Alimta (pemetrexed), a first-line therapy developed by Eli Lilly designed to treat people with pleural mesothelioma. The FDA allows...

Edward Keller to launch CRO business in Korea.

Edward Keller, a Korea branch of the multinational commercial company named Diethelm Keller Siber Hegner, started a CRO business in Korea. The company has mainly engaged in the ...

Listed drug companies to achieve stable and profitable management.

Amid a sustained general economy recession the pharmaceutical industries have stressed their business strategies into a more stable and profitable management direction. All listed drug companies having a fiscal ye...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.